vilazodone
Megjelenés
| Clinical data | |
|---|---|
| Pronunciation | /vɪˈlæzədoʊn/ vi-LAZ-ə-dohn |
| Trade names | Viibryd |
| Other names | EMD-68843; SB-659746A |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a611020 |
| License data |
|
| Routes of administration | By mouth |
| Drug class | Serotonin modulator |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 72% (oral, with food) |
| Metabolism | Liver via CYP3A4 |
| Elimination half-life | 25 hours |
| Excretion | Faecal and renal |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank |
|
| ChemSpider | |
| UNII |
|
| KEGG | |
| ChEBI |
|
| ChEMBL |
|
| PDB ligand | |
| Chemical and physical data | |
| Formula | C26H27N5O2 |
| Molar mass | 441.535 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Főnév
vilazodone (tsz. vilazodones)
- vilazodone - Szótár.net (en-hu)
- vilazodone - Sztaki (en-hu)
- vilazodone - Merriam–Webster
- vilazodone - Cambridge
- vilazodone - WordNet
- vilazodone - Яндекс (en-ru)
- vilazodone - Google (en-hu)
- vilazodone - Wikidata
- vilazodone - Wikipédia (angol)